Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases

Summary

Primary endpoint of the study is to prove the superiority of an adjuvant therapy with oxaliplatin/ capecitabine until the first occurrence of appearance of a tumour. Occurrences in the meaning of this study are the appearance of a relapse of the tumour, of metastases, of a second tumour or death of any reason.

Timeline

Start

2004-11

Primary completion

—

Completion

—

Drugs

Indications